Many of the world's most important infectious diseases are transmitted to humans by insect vectors. Attempts to eliminate the insect vectors or to immunize and protect the human host have thus far been unsuccessful. Alteration of insect vector competence is an alternative strategy to interrupt the cycle of disease transmission. Preliminary data from the Principal Investigator's laboratory document the unique capability of retroviral vectors containing the envelope glycoprotein of vesicular stomatitis virus (VSV-G) to infect and stably integrate into a broad range of non-mammalian cells including fish, frog, newt, and insect cells. These pantropic, replication-incompetent vectors have been used to create transgenic fish with stable, Mendelian segregation of the provirus in the F2 generation. The collaborating investigators have demonstrated that microinjection of mosquito eggs with concentrated viral stocks results in a high percentage of adult transformants containing the provirus. Using a Sindbis vector expression system, the collaborating investigators have shown protection of mosquito cells expressing the nucleocapsid gene of flaviviruses from superinfection with the homologous viral strain. These data suggest that pantropic retroviral vectors can be used to genetically modify insects to prevent transmission of important human pathogens. The proposed project will bring together three different investigators with established expertise in mosquito vector biology, virology, and retroviral vector design with the following goals: 1) to develop VSV-G pseudotyped retroviral vectors that mediate stable gene expression in mosquito cell lines and in transgenic progeny of germline transformants and 2) to create transgenic mosquitoes with a pantropic retroviral vector expressing the nucleocapsid gene of different flaviviruses, to confer cellular resistance to superinfection following challenge with wild type virus. The current proposal is a unique opportunity to develop a transformation system for the mosquito vector community that will permit the testing of strategies to alter mosquito vector competence to prevent vector-borne disease transmission.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
Research Project (R01)
Project #
5R01AI037671-03
Application #
2390426
Study Section
Special Emphasis Panel (ZRG5-TMP (01))
Project Start
1995-04-01
Project End
1999-03-31
Budget Start
1997-04-01
Budget End
1999-03-31
Support Year
3
Fiscal Year
1997
Total Cost
Indirect Cost
Name
University of California San Diego
Department
Pediatrics
Type
Schools of Medicine
DUNS #
077758407
City
La Jolla
State
CA
Country
United States
Zip Code
92093
Que, X; Kim, D; Alagon, A et al. (1999) Pantropic retroviral vectors mediate gene transfer and expression in Entamoeba histolytica. Mol Biochem Parasitol 99:237-45
Higgs, S; Rayner, J O; Olson, K E et al. (1998) Engineered resistance in Aedes aegypti to a West African and a South American strain of yellow fever virus. Am J Trop Med Hyg 58:663-70
Jordan, T V; Shike, H; Boulo, V et al. (1998) Pantropic retroviral vectors mediate somatic cell transformation and expression of foreign genes in dipteran insects. Insect Mol Biol 7:215-22
Franco, M; Rogers, M E; Shimizu, C et al. (1998) Infection of lepidoptera with a pseudotyped retroviral vector. Insect Biochem Mol Biol 28:819-25
Matsubara, T; Beeman, R W; Shike, H et al. (1996) Pantropic retroviral vectors integrate and express in cells of the malaria mosquito, Anopheles gambiae. Proc Natl Acad Sci U S A 93:6181-5
Higgs, S; Traul, D; Davis, B S et al. (1996) Green fluorescent protein expressed in living mosquitoes--without the requirement of transformation. Biotechniques 21:660-4